Former FDA Official Criticizes COVID-19 Guidance’s Silence On Biosimilars
Eva Temkin Highlights Unanswered Questions On 180-Day Exclusivity
• By Akriti Seth
Eva Temkin criticizes the silence of recently issued FDA guidance on important topics • Source: Alamy 
